Alpha DNA Company Profile

18:56 EDT 22nd June 2018 | BioPortfolio



4401 Notre-Dame St. W
H4C 3N9


Phone: 800-511-3654

News Articles [192 Associated News Articles listed on BioPortfolio]

First John W. Walsh Translational Research Award granted

(Boston University School of Medicine) The Alpha-1 Foundation celebrates the first granting of the John W. Walsh Translational Research Award in Alpha-1 Antitrypsin Deficiency, an honorable award name...

BU medical student receives student fellowship from Alpha Omega Alpha

(Boston University School of Medicine) Melissa Chua, a fourth-year medical student at Boston University School of Medicine (BUSM), has received the Alpha Omega Alpha (AOA) Carolyn L. Kuckein Student R...

Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

REHOVOT, Israel, April 23, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the Company recentl...

Alpha 1 Antitrypsin Deficiency Treatment Market: High Unmet Demand in ...

A recent intelligence study by Transparency Market Research has detected that the global alpha-1 antitrypsin deficiency treatment market is divided among a vast number of global and regional players. ...

Pharnext veröffentlicht Ergebnisse für das Geschäftsjahr 2017

Pharnext SA (Paris:ALPHA) (FR00111911287 ALPHA), ein französisches biopharmazeutisches Unternehmen und Pionier eines neuen Ansatzes zur Entwicklung innovativer Arzneimittelkombinationen auf der Ba...

Pharnext wirbt erfolgreich 16 Mio. Euro im Rahmen einer Privatplatzierung ein

Pharnext SA (Paris:ALPHA) (FR0011191287 ALPHA), ein biopharmazeutisches Unternehmen und Pionier eines neuen Ansatzes zur Entwicklung innovativer Medikamentenkombinationen, die auf Big Data aus dem...

Pharnext Successfully Raises €16 Million via Private Placement

Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big genomic data ...

LG Lays Groundwork For TV Of Tomorrow With ThinQ® And α (Alpha) Processor

"As a leading innovator in the TV industry, LG is pleased to introduce the LG ThinQ and α (Alpha) 9 processor for an unrivaled viewing Read more...

Drugs and Medications [156 Associated Drugs and Medications listed on BioPortfolio]

Isa knox x2d2 wrinkle serum [LG Household and Healthcare, Inc.]

Drug Facts

Doxazosin [Apotex Corp.]

DOXAZOSIN TABLETS, USP 1 mg, 2 mg, 4 mg and 8 mg

Cardura [Roerig]

CARDURA® (doxazosin mesylate) Tablets

Doxazosin mesylate [Golden State Medical Supply, Inc.]


Doxazosin mesylate [Major Pharmaceuticals]


PubMed Articles [469 Associated PubMed Articles listed on BioPortfolio]

Postanoxic alpha, theta or alpha-theta coma: clinical setting and neurological outcome.

The aim of this study was to determine the prognosis of 26 consecutive adults with alpha coma (AC), theta coma (TC) or alpha-theta coma (ATC) following CRA and to describe the clinical setting and EEG...

Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

HPV variants from the same type can be classified into lineages and sublineages based on the complete genome differences and the phylogenetic topologies. We examined nucleotide variations of twelve HP...

Alpha particle spectroscopy using FNTD and SIM super-resolution microscopy.

Structured illumination microscopy (SIM) for the imaging of alpha particle tracks in fluorescent nuclear track detectors (FNTD) was evaluated and compared to confocal laser scanning microscopy (CLSM)....

Anti-aging factor, serum alpha-Klotho, as a marker of acute physiological stress, and a predictor of ICU mortality, in patients with septic shock.

Genetic deletions decreasing serum alpha-Klotho (alpha-KL) have been associated with rapid aging, multi-organ failure and increased mortality in experimental sepsis. We hypothesized that lower alpha-K...

Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis.

IgE antibodies (Ab) specific to galactose-α-1,3-galactose (alpha-gal) are responsible for a delayed form of anaphylaxis that occurs 3 to 6 hours after red meat ingestion. In a unique prospective stud...

Clinical Trials [890 Associated Clinical Trials listed on BioPortfolio]

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

The purpose of the study is to test safety and efficacy of different doses of thymosin alpha 1 (1.6 mg, 3.2 mg, and 6.4 mg) in combination with dacarbazine and with or without Interferon a...

The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency

The purpose of this clinical study is to assess the safety and tolerability of Alpha-1 MP in adult Alpha1-antitrypsin deficient patients.

Alpha-1 Foundation Research Registry

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

Alpha MSH in Ocular Disease

The purpose of this study is gain a better understanding of a molecule called alpha melanocyte stimulating hormone (alpha MSH) and its potential role in your retinal disease. Alpha MSH has...

Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis

This is a single-center, open-label, multiple-dose study of the efficacy and long-term safety of Lamazym for the treatment of patients with alpha-mannosidosis.

Companies [88 Associated Companies listed on BioPortfolio]

Alpha-1 Foundation

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

The Alpha-1 Project

Mission statement: The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures ...

Alpha-1 Foundation and Foundation for Sarcoidosis Research

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...


Alpha-Stim is an industry leader in cranial electrotherapy stimulation (CES) devices, providing treatment for anxiety, depression, insomnia and pain, without the side effects comm...

Alpha Pro Tech, Ltd.

Alpha Pro Tech, Ltd. is the parent company of Alpha Pro Tech, Inc., and Alpha ProTech Engineered Products, Inc. Alpha Pro Tech, Inc. develops, manufactures and markets innovative ...

More Information about "Alpha DNA" on BioPortfolio

We have published hundreds of Alpha DNA news stories on BioPortfolio along with dozens of Alpha DNA Clinical Trials and PubMed Articles about Alpha DNA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alpha DNA Companies in our database. You can also find out about relevant Alpha DNA Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record